On September 19, 2019 the WIB San-Francisco Bay Area Chapter and Foley & Lardner LLP hosted a panel discussion on the future of pharmaceutical pricing and its impact on public health. The roundtable was moderated by Sara Singer (Professor of Medicine, Stanford University School of Medicine and Professor, by courtesy, at the Stanford Graduate School of Business and Freeman Spogli Institute for International Studies). Panelists included Katie Gudiksen (Senior Health Policy Researcher for The Source on Healthcare Price and Competition), Robin Howard (V.P. of Commercial Planning at Global Blood Therapeutics), and Allison Dupuy (Managing Partner and U.S. Head of Life Sciences at Simon-Kucher & Partners).
Click here for more photos
The illustrious panel provided nuanced and detailed perspectives on proposed payer solutions and their potential implications on drug pricing, access, and the overall healthcare landscape. The event was attended by 28 industry professionals, and attendees walked away with an in-depth understanding of the complexities and stakeholders embedded within the US healthcare challenges. Some attendees reported that the panel was “super informative” and will help them serve their clients better with exclusive insights.